Page last updated: 2024-11-05

tolbutamide and Autosomal Dominant Juvenile Parkinson Disease

tolbutamide has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 3 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HELLER, GL1
DEJONG, RN1
MAGEE, KR1
SCHWARTZ, W1
Brown, JD1
Stone, DB1

Other Studies

3 other studies available for tolbutamide and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Tolbutamide in the treatment of parkinsonism.
    JAMA, 1961, Apr-15, Volume: 176

    Topics: Parkinson Disease; Parkinsonian Disorders; Tolbutamide

1961
MEBUTAMATE AND HYDROCHLOROTHIAZIDE IN HYPERTENSION.
    Journal of the American Geriatrics Society, 1964, Volume: 12

    Topics: Antihypertensive Agents; Arthritis; Arthritis, Rheumatoid; Blood Pressure Determination; Carbamates;

1964
TOLBUTAMIDE-INDUCED HYPOGLYCEMIA.
    The American journal of clinical nutrition, 1964, Volume: 15

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Chlorpropamide; Diabetes Mellitus; Drug Therapy; Female;

1964